Bioinformatics - ProtaGene

Cell & Gene Analytics

Bioinformatics – NGS Data Analytics

hero-animation

Bioinformatics—Sequencing Data Analytics

Our proprietary data analysis pipelines are a vital pillar of our service offerings for gene therapy safety assessment. In addition to our regular service packages, our highly accomplished bioinformatics team can develop customized secondary analyses to gain deeper biological insights into integration site datasets, on-/off-target studies or vector quality control assessments.

ProtaGene’s bioinformatics team expertise in the analysis of genomics datasets, such as WGS, RNAseq or methylome, also allows us to offer a unique and comprehensive approach enabling the multidimensional assessment of eventual severe adverse events or specific biological questions.

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Cell and Gene Therapeutic Platform Expertise

Our deep experience assembling a broad range of cell and gene therapy platforms from research through commercialization helps the ProtaGene team design highly effective analytical programs that de-risk development and accelerate timelines to your next key milestones. Key cell and gene therapy platform development areas include:

  • bullet Created with Sketch.

    Capsid-based Vectors

    • AAVs (Multiple Serotypes and Engineered Vectors)
    • Novel Systems
    • Adenovirus
  • bullet Created with Sketch.

    Complex, Envelope Vectors

    • Lentivirus
    • Gammaretrovirus 
    • Novel Viruses
  • bullet Created with Sketch.

    Non-viral Vectors

    • Polynucleotide (RNA/DNA) Formulations
    • Lipid Nanoparticles
    • Transposons
    • Plasmids
  • bullet Created with Sketch.

    Genetic Engineering

    • TALEN
    • CRISPR/Cas9
    • Zinc-finger Nucleases
Our Analytical Systems_Left Created with Sketch.

Analytical Systems

Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.

Our Analytical Systems_right Created with Sketch.

Subscribe to Our Email List

Consent

Talk to Our Experts

Discover how ProtaGene can support your development programs

Contact Us